HIGH GRADE GLIOMA

dc.contributor.authorSalokhiddinov Khabibullo Adhamjon ugli
dc.date.accessioned2025-12-30T07:51:21Z
dc.date.issued2025-12-19
dc.description.abstractHigh-grade gliomas (HGGs) are a category of aggressive brain tumors with poor prognosis and limited treatment options. These tumors are characterized by their rapid growth, invasive nature, and resistance to conventional therapies. This article explores the current understanding of high-grade gliomas, including their pathophysiology, diagnosis, and treatment options. The review highlights the challenges in managing these tumors, the latest research findings, and potential future therapeutic strategies. Early diagnosis and novel therapeutic approaches, such as immunotherapy and personalized medicine, are also discussed as promising avenues for improving patient outcomes.
dc.formatapplication/pdf
dc.identifier.urihttps://europeanscience.org/index.php/3/article/view/1626
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/27744
dc.language.isoeng
dc.publisherEuropean Science Publishing
dc.relationhttps://europeanscience.org/index.php/3/article/view/1626/1540
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceEuropean Science Methodical Journal; Vol. 3 No. 12 (2025): ESMJ; 14-18
dc.source2938-3641
dc.subjectHigh-grade glioma, glioblastoma, brain tumor, treatment, immunotherapy, personalized medicine, prognosis, biomarkers.
dc.titleHIGH GRADE GLIOMA
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
ugli_2025_high_grade_glioma.pdf
item.page.filesection.size
165.02 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections